An increasing body of evidence suggests that inhibition of PFKFB3 by chemical inhibitors or genetic attenuation significantly reduced glycolytic flux, ras-based transformation, and tumor growth in athymic mice [13–15]. Here, PFKFB3 is linked to neoplasm.